Biochemical and Cellular Evidence Demonstrating AKT-1 as a Binding Partner for Resveratrol Targeting Protein NQO2
Tze-chen Hsieh(New York Medical College), Joseph Wu(Pfizer (United States))
Cited by 32
Related Papers
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling
|International Journal of Oncology|2018|104
Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An <i>in silico</i> and biochemical approach targeting integrin αvβ3
|International Journal of Cancer|2011|68
AKT/mTOR as Novel Targets of Polyphenol Piceatannol Possibly Contributing to Inhibition of Proliferation of Cultured Prostate Cancer Cells
|ISRN Urology|2012|45
Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells
|Carcinogenesis|2012|45